ASTH

Astrana Health, Inc.
$36.81
-1.22 (-3.21%)
Mkt Cap 1.83B
Volume 147,057
52W Range 18.08-51.6
Sector Healthcare
Beta 0.91
EPS (TTM) 0.83 USD
P/E Ratio 44.48
Revenue (TTM) 3.84B USD
Rev Growth (5Y) +53.8%
EPS Growth (5Y) -15.1%
AlphaVal · Fair Value
What we estimate one share is worth
$80.37
Undervalued strong signal
54.2% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
C-
Platform & Compounding FCF
46.8 / 100 composite
A platform business that compounds free cash flow — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2015
Revenue 3.18B 2.03B 1.39B 1.14B 773.91M 370.25M 560.62M 519.91M 357.75M 44.05M
Net Income 22.49M 43.15M 60.72M 45.17M 68.92M (23.75M) 14.12M 10.84M 25.80M (9.34M)
EPS 0.46 0.91 1.30 1.00 1.57 1.04 0.41 0.33 1.01 0.00
Free Cash Flow 104.49M 44.17M 39.70M 59.19M 51.11M 45.00M 12.63M 24.93M 50.99M (2.10M)
FCF / Share 2.13 0.93 0.85 1.32 1.17 1.23 0.36 0.76 2.00 N/A
Operating CF 114.60M 52.20M 68.23M 82.13M 70.33M 46.16M 13.67M 26.10M 53.07M (1.84M)
Total Assets 2.22B 1.35B 933.36M 966.21M 867.36M 817.49M 728.71M 513.00M 490.64M 19.57M
Total Debt 1.08B 471.84M 321.01M 229.36M 200.98M 260.56M 256.55M 13.66M 6.25M 188,764
Cash & Equiv 429.47M 288.45M 293.81M 288.03M 233.10M 193.47M 103.19M 106.89M 119.77M 9.27M
Book Value 779.29M 712.72M 614.22M 542.56M 448.17M 330.82M 191.55M 180.55M 159.95M 5.81M
Return on Equity 0.03 0.06 0.10 0.08 0.15 -0.07 0.07 0.06 0.16 -1.61
ASTH News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
Oct 15, 2026 06:00 AM · prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
Oct 13, 2026 01:08 PM · globenewswire.com
Is It Too Late to Buy Astrana Health Inc (ASTH) After 4.7% Rally? GF Value Says Undervalued
Oct 09, 2026 04:05 PM · gurufocus.com
Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call
Oct 09, 2026 12:05 PM · prnewswire.com
Why Astrana Health, Inc. (ASTH) is Poised to Beat Earnings Estimates Again
Oct 09, 2026 09:10 AM · zacks.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
Oct 08, 2026 06:00 AM · prnewswire.com
Astrana Health, Inc. (NASDAQ:ASTH) Stock Rated “Moderate Buy” by Wall Street Analysts
Oct 08, 2026 12:29 AM · defenseworld.net
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
Oct 06, 2026 12:38 PM · globenewswire.com
Head to Head Review: Tenet Healthcare (NYSE:THC) and Astrana Health (NASDAQ:ASTH)
Oct 04, 2026 10:58 PM · defenseworld.net
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
Oct 01, 2026 06:00 AM · prnewswire.com